Coya Therapeutics (COYA) Revenue (2023 - 2026)

Coya Therapeutics has disclosed Revenue across 4 years of filings, most recently posting $243745.0 for Q2 2026.

• In Q2 2026, Revenue rose 48.97% year-over-year to $243745.0; the TTM figure through Jun 2026 stood at $8.0 million (up 1793.76% YoY), while the FY2025 annual figure was $7.9 million, up 123.57% from the prior year.
• Revenue came in at $243745.0 for Q2 2026 at Coya Therapeutics, down from $251147.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $6.0 million in Q4 2023 to a low of $1952.0 in Q4 2024.
• Average Revenue over 4 years is $1.8 million, with a median of $254515.5 recorded in 2025.
• Year-over-year, Revenue tumbled 99.97% in 2024 and jumped 202768.8% in 2025.
• Over 4 years, Revenue stood at $6.0 million in 2023, then plunged by 99.97% to $1952.0 in 2024, then jumped by 202768.8% to $4.0 million in 2025, then slumped by 93.84% to $243745.0 in 2026.
• Per Business Quant data, the three most recent Revenue figures were $243745.0 in Q2 2026, $251147.0 in Q1 2026, and $4.0 million in Q4 2025.